Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - TOTAL CURRENT ASSETS
Total Current Assets SMMT - Summit Therapeutics Inc.
190 M
LAST VALUE
39.63%
2 YEAR CAGR
25.35%
5 YEAR CAGR
43.55%
10 YEAR CAGR